-
International Journal of Women's Health
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Hot flashes in breast cancer survivors and an association with calcium supplement use
Original Research
(1606) Views (429) Full article downloads
Authors: Gretchen Kimmick, Gloria Broadwater, Mara Vitolins
Published Date August 2010
Volume 2010:2 Pages 291 - 294
DOI: http://dx.doi.org/10.2147/IJWH.S12335
Gretchen Kimmick1,2, Gloria Broadwater2, Mara Vitolins31Medical Oncology, Wake Forest University School of Medicine, Winston-Salem; 2Cancer Center Biostatistics, Duke University Medical Center, Durham; 3Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA
Aims: In breast cancer survivors, we aimed to describe the frequency of hot flashes and night sweats, frequency and type of treatment, and the association of hot flashes and use of calcium supplements.
Methods: Charts of breast cancer survivors were reviewed for information about hot flashes, treatment for hot flashes, and calcium supplementation. Associations between variables were explored using the Chi-square test and Fisher’s Exact test.
Results: Eighty-six charts were reviewed. Mean age of the women was 58 years and 79% were postmenopausal. Forty-two (49%) of women had hot flashes and 18 (21%) had night sweats. Thirty-one (36%) were treated for hot flashes. Treatment included selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors (n = 19), clonidine (n = 7), Bellergal-S® (n = 8), sleep-aid (n = 7), and other (n = 5). Calcium supplementation was recorded in 31%. Of women with hot flashes, 44% took calcium supplements; of women without hot flashes, 18% took calcium supplements (Chi-square P = 0.02).
Conclusion: Hot flashes were recorded in 49% of this group of primarily postmenopausal breast cancer survivors. Women with hot flashes were more likely to be taking calcium supplements. Further exploration of the association between hot flashes and calcium supplementation is warranted.
Keywords: hot flashes, breast cancer, calcium supplementation
- Interested in being a peer-reviewer?
Click here to register.
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Contraceptive practices in Nigeria: Literature review and recommendation for future policy decisions
- Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy
- Diagnosis and management of pre-eclampsia: an update
- Raising HDL cholesterol in women




